ONE WORLD | ONE FIGHT
Global Platform for Breast Cancer and other Female Cancers
Fund the science that saves lives. Not galas. Not ribbons. Research.
85% of every donation funds research →Cancer doesn’t fly
business class.
Neither do we.
Most cancer charities can’t tell you where your money goes. We name the scientist, the institution, the TRL level, and the cancer type. Every grant. Every dollar.
Every action moves the science forward. Choose the path that fits you.
Your donation goes directly to TRL 3–5 research at verified institutions. 85 cents of every dollar. Tracked to the grant.
Align your brand with verifiable science. Named researcher, named institution, named TRL level. Not pink-washing — proof.
Share our mission. Follow our research updates. Help us reach the people who believe science should come first.
85 cents of every dollar funds research. 15 cents runs the entire operation. This isn’t a target. It’s a constraint encoded in our bylaws.
We fund research across all female gender-related cancers: gynaecological cancers that only affect women, plus breast cancer.
Tile colour reflects research attention and funding. Lightest pinks mark the cancers most commonly discussed — deeper pinks highlight the rare and under-researched ones that receive far less support.
Most common
Preventable
Silent killer
Often grouped with ovarian
Rising incidence
Very rare
Under-researched
“We name the scientist, the institution, and the exact TRL level your donation funded.”
Most funding goes to basic research (TRL 1–2) or late-stage trials (TRL 6–9). The critical middle is chronically underfunded. Pharma won’t touch it. Governments overlook it. We exist to fill that gap.
TRL 3–5 is where discoveries have proven their concept but can’t attract pharmaceutical investment. A BRCA marker identified at Queen’s Belfast. A detection method validated at MD Anderson. Without bridge funding, this science simply dies. We make sure it doesn’t.
The science works in the lab. Needs validation in relevant biological systems.
Results confirmed in disease models. The mechanism is real. Capital needed.
Strong data. The tipping point where pharma pays attention — if science gets here.
“The gap between discovery and cure isn’t scientific — it’s financial.”
Named scientists at verified institutions, doing published work you can look up yourself.
Every grant is evaluated by independent scientists before a single dollar moves. Rigour only.
Tax-deductible. Secure via Stripe or PayPal. Tracked from arrival.
Independent scientists evaluate for rigour and TRL 3–5 alignment.
85% flows to approved research. Named institution. Named researcher.
Open updates. Annual reports. Full financial transparency.
Real researchers. Real breakthroughs. Stories from the labs your donations fund.
How a TRL 3 discovery at Queen’s University Belfast moved closer to clinical validation — funded by donors like you.
Early-stage detection research that could change survival rates — currently at TRL 4 and advancing.
Tata Medical Centre researchers developing affordable screening methods for underserved populations.
ONE WORLD | ONE FIGHT
Monthly donors receive quarterly briefings — named researchers, real results, actual science.
Donate nowOne movement, 96 countries. Every highlighted nation stands with PinkRibbon International.